Cumulative cause-specific mortality for cancer patients in the presence of other causes: A crude analogue of relative survival

Statistics in Medicine

Volumn 19, Issue 13, 2000, Pages 1729-1740

  Cronin, Kathleen A ^a   Feuer, Eric J ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; BREAST CANCER; CANCER MORTALITY; CANCER STATISTICS; CANCER SURVIVAL; FEMALE; HUMAN; MALE; PROBABILITY; PROSTATE CANCER; STATISTICAL ANALYSIS;

AGED; ANALYSIS OF VARIANCE; BREAST NEOPLASMS; CAUSE OF DEATH; COHORT STUDIES; FEMALE; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; PROSTATIC NEOPLASMS; REGISTRIES; SEER PROGRAM; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 0034661773     PISSN: 02776715     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0258(20000715)19:13<1729::AID-SIM484>3.0.CO;2-9     Document Type: Article

References (21)

1. Prentice RL, Kalbfleisch JD, Peterson AV, Flournoy N, Farewell VT, Breslow NE. The analysis of failure times in the presence of competing risks. Biometrics 1978; 34:541-554.
2. Elandt-Johnson RC, Johnson NL. Survival Models and Data Analysis. Wiley: New York, 1980.
3. Cutler SJ, Ederer F, Griswold MH, Greenberg RA. Survival of breast-cancer patients in Connecticut, 1935-54. Journal of the National Cancer Institute 1959; 23:1137-1156.
4. Extramural Committee to Assess Measures of Progress Against Cancer. Special report measurement of progress against cancer. Journal of the National Cancer Institute 1990; 82:825-835.
5. Gaynor JJ, Feuer EJ, Tan CC, Wu DH, Little CR, Straus DJ, Clarkson BD, Brennan MF. On the use of cause-specific failure and conditional failure probabilities: examples from clinical oncology data. Journal of the American Statistical Association 1993; 88:400-409.
6. Percy CL, Miller BA, Ries LA. Effect of changes in cancer classification and accuracy of cancer death certificates on trend of cancer mortality. In Trends in Cancer Mortality in Industrial Countries, Davis DL, Hoel D (eds). New York Academy of Science: New York, 1990; 87-99.
7. Brown BW, Brauner C, Minnotte MC. Noncancer deaths in white adult cancer patients. Journal of the National Cancer Institute 1993; 85:979-987.
8. Ederer F, Axtell LM, Cutler SJ. The Relative Survival Rate: a Statistical Methodology. Monograph, National Cancer Institute: Bethesda, Maryland, 1961; 101-121.
9. Ries LAG, Kosary CL, Hankey BF, Miller BA, Harras A, Edwards BK (eds). SEER Cancer Statistics Review, 1973-1994. National Cancer Institute, NIH Pub. No.97-2789: Bethesda, Maryland, 1997.
10. Hakulinen T, Abeywickrama KH. A computer program package for relative survival analysis. Computer Programs in Biomedicine 1985; 19:197-207.
11. Cutler SJ, Ederer F. Maximum utilization of the lifetable method in analyzing survival. Journal of Chronic Diseases 1955; 8:699-712.
12. Hakulinen T. Net probabilities in the theory of competing causes. Scandinavian Actuarial Journal 1977; 65-88.
13. Hakulinen T. Cancer survival corrected for heterogeneity in patient withdrawal. Biometrics 1982; 38:933-942.
14. Hakulinen T. On long-term relative survival rates. Journal of Chronic Diseases 1977; 30:431-443.
15. Esteve J, Benhamou E, Croasdale M, Raymond L. Relative survival and the estimation of net survival: elements for further discussion. Statistics in Medicine 1990; 9:529-538.
16. Ries LAG, Kosary CL, Lyles LPN. Cancer patient survival: why use the relative survival rates? The Abstract 1995; 22:28-30.
17. Blesch KS, Freels S, Furner S, Davis F, Miles TP. Applying the realized probability of dying to cancer survival. Journal of Clinical Epidemiology 1996; 49:879-884.
18. Brown BW, Brauner C, Levy LB. Assessing changes in the impact of cancer on population survival without considering cause of death. Journal of the National Cancer Institute 1997; 89:58-65.
19. Gooley TA, Leisnring W, Crowley J, Storer BE. Estimation of failure probability in the presence of competing risks: new representations of old estimators. Statistics in Medicine 1999; 18:695-706.
20. Gamel JW, Meyer JS, Feuer EJ, Miller BA. The impact of stage and history on the long-term clinical course of 163,808 patients with breast carcinoma. Cancer 1996; 77:1459-1464.
21. Haybittle JL. Curability of breast cancer. British Medical Bulletin 1990; 47:319-323.